Product information and disease descriptionProduct descriptionProduct information
Dosage forms and strengths
4 evidence topics · 4 sources
Dosage form in phase 3: solution for intravitreal injection
Molecule and dose volume in ARCHER II: 5 mg in 25 microliters
Expression system and glycosylation
Doses and injection volumes in the phase 1 glaucoma studies
Concentration, commercial presentation, packaging, and storage
No evidence found.